Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C

References

• Davis KL, Mitra D, Medjedovic J, et al. Direct economic burden of chronic hepatitis C virus in a United States managed care population. J Clin Gastroenterol 2011;45:e17-24
   PubMed Web of Science ®Google Scholar
• McAdam-Marx C, McGarry LJ, Hane C a, et al. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective. JMCP 2011;17:531-46
   PubMed Web of Science ®Google Scholar
• McCombs JS, Yuan Y, Shin J, et al. Economic burden associated with patients diagnosed with hepatitis C. Clin Therapeut 2011;33:1268-80
   PubMed Web of Science ®Google Scholar
• Poret AW, Ozminkowski RJ, Goetzel R, et al. Cost burden of illness for Hepatitis C patients with employer-sponsored health insurance. Dis Manag 2002;5:95-107
   Google Scholar
• Razavi H, Elkhoury AC, Elbasha E, et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology (Baltimore, MD) 2013;57:2164-70
   PubMed Web of Science ®Google Scholar
• Rosenberg DM, Cook SF, Lanza LL. Health care, treatment patterns and cost of services for patients infected with chronic hepatitis C virus in a large insured New England population. J Viral Hepatitis 2000;7:361-7
   PubMed Web of Science ®Google Scholar
• Su J, Brook R a, Kleinman NL, et al. The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs. Hepatology (Baltimore, MD) 2010;52:436-42
   PubMed Web of Science ®Google Scholar
• Tandon N, Reddy KR, Lefebvre P, et al. Direct and indirect cost burden of chronic Hepatitis C infection in privately-insured patients, stratified by liver disease severity. Am J Pharm Benefits 2015;7:e90-e100
   Web of Science ®Google Scholar
• Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014;160:293-300
   PubMed Web of Science ®Google Scholar
• Armstrong GL. The prevalence of Hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705
   PubMed Web of Science ®Google Scholar
• Davis GL, Alter MJ, El-Serag H, et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010;138:513-21, 521.e1-6
   PubMed Web of Science ®Google Scholar
• Ly KN, Xing J, Monina Klevens R, et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012;156:271-278
   PubMed Web of Science ®Google Scholar
• Rein DB, Wittenborn JS, Weinbaum CM, et al. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Digest Liver Dis 2011;43:66-72
   Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology (Baltimore, MD) 2001;33:464-70
   PubMed Web of Science ®Google Scholar
• Gordon SC, Pockros PJ, Terrault N, et al. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection. Hepatology (Baltimore, MD) 2012;56:1651-60
   PubMed Web of Science ®Google Scholar
• Smith DH, Malone DC, Lawson K a, et al. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997;156:787-93
   PubMed Web of Science ®Google Scholar
• Nihcm Foundation. The Concentration of Health Care Spending. 2012 Washington, DC
   Google Scholar
• Basseri B, Yamini D, Chee G, et al. Comorbidities associated with the increasing burden of hepatitis C infection. Liver Int Off J Int Assoc Study Liver 2010;30:1012-18
   PubMed Web of Science ®Google Scholar
• El-Zayadi A-R. Hepatitis C comorbidities affecting the course and response to therapy. World J Gastroenterol 2009;15:4993
   PubMed Web of Science ®Google Scholar
• Jacobson IM, Cacoub P, Dal Maso L, et al. Manifestations of chronic hepatitis C virus infection beyond the liver. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2010;8:1017-29
   PubMed Web of Science ®Google Scholar
• Khattab MA, Eslam M, Alavian SM. Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection. Hepatitis Monthly 2010;10:258-69
   PubMed Web of Science ®Google Scholar
• Ko HM, Hernandez-Prera JC, Zhu H, et al. Morphologic features of extrahepatic manifestations of hepatitis C virus infection. Clin Dev Immunol 2012;2012:740138
   PubMedGoogle Scholar
• Huang Y-W, Yang S-S, Fu S-C, et al. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study. Hepatology 2014;60:807-14
   PubMed Web of Science ®Google Scholar
• AASLD/IDSA HCV Guidance Panel. Hepatitis C Guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with Hepatitis C Virus. Hepatology 2015;62:932-54
   PubMed Web of Science ®Google Scholar
• Moon C, Jung KS, Kim DY, et al. lower incidence of hepatocellular carcinoma and cirrhosis in Hepatitis C patients with sustained virological response by pegylated interferon and ribavirin. Digest Dis Sci 2014;60:573–81
   PubMed Web of Science ®Google Scholar
• Fransen van de Putte DE, Makris M, Fischer K, et al. Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders. J Hepatol 2014;60:39-45
   PubMed Web of Science ®Google Scholar
• Manos MM, Darbinian J, Rubin J, et al. The effect of hepatitis C treatment response on medical costs: a longitudinal analysis in an integrated care setting. JMCP 2013;19:438-47
   PubMed Web of Science ®Google Scholar
• McCombs J, Matsuda T, Tonnu-Mihara I, et al. The risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a Department of Veterans Affairs Clinical Registry. JAMA Intern Med 2014;174:204-12
   PubMed Web of Science ®Google Scholar
• Tandon N, Balart L a, Laliberté F, et al. Impact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare cost. J Med Econ 2014;17:1-10
   PubMedGoogle Scholar
• Ong JP, Collantes R, Pitts A, et al. High rates of uninsured among HCV-positive individuals. J Clin Gastroenterol 2005;39:826-30
   PubMed Web of Science ®Google Scholar